Biosimilars 2020 Year in Review
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
The parties are currently engaged in supplemental expert discovery on Hospira and Pfizer’s on-sale bar and public use defenses, and the court has resolved two discovery disputes this year stemming from these issues. license and the ability to bring a biosimilar to market in March 2025. A jury trial is scheduled for May 17, 2021.
52 
Let's personalize your content